Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

American College of Cardiology now supports early use of medication to treat obesity

The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles in any treatment decisions. 

artificial intelligence AI in healthcare

Healthcare AI today: Senate arguments, aging infrastructure, ‘elastic’ jobs, more

States’ rights or federal power? Senate Republicans are of two minds on AI regulation in the One Big Beautiful Bill. 

Hospital

That’s no mere hospital—it’s a ‘complex adaptive system.’ Use GenAI accordingly.

From the perspective of management science, healthcare is a complex adaptive system marked by intricate feedback loops and overlapping interdependencies. As such, the sector demands caution by those introducing large-language AI into its tangled webs. 

AI in mental healthcare

Healthcare AI today: Dangerous LLMs, self-training AI—and is AI good for what ails healthcare?

If an individual is at all susceptible to mental unwellness, overuse of a talkative LLM could push him or her over the edge. Maybe literally. 

artificial intelligence AI for mental healthcare therapy

3 points to ponder before tapping AI for mental healthcare

Earlier this year, patients treated by an AI chatbot for some common mental health challenges got better. This was significant because the patients were part of the first randomized and controlled trial for this type of AI intervention. 

money maze payment reimbursement

Why more doctors should pursue business and leadership training

“Just as medicine has its own language, so does business," two surgeons explained in a new editorial. 

Next-day discharge after TAVR is still safe when alternative access is required

Even TAVR patients not treated using transfemoral access can typically go home the very next day. 

Hemal Gada, MD, cardiologist

Q&A: Cardiologist and EARLY TAVR co-author questions study’s execution

The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of asymptomatic patients. However, one cardiologist who participated in the trial has some serious concerns with how its findings were presented to the public.